The latest learning and CPD content on women's health. Under ‘Other resources’ you will find all our other content related to women's health.
CPD and Learning
Early diagnosis and multi-modal treatment is necessary to improve quality of life in adolescents and women with endometriosis.
Heavy menstrual bleeding has a major impact on a woman’s quality of life. This article covers the most recent guidance and available treatment options.
Treatment options for menopausal symptomsSubscription
Pharmacists and healthcare professionals can provide a patient-centred approach to advising women about the menopause, and provide robust information about the risks and benefits of menopause hormone treatment that will allow patients to make an informed choice about how to relieve their symptoms.
Pharmacists and healthcare professionals can provide appropriate and comprehensive preconception care by identifying couples who are at risk of having a baby with a genetic or chromosomal malformation and can empower the couple by giving them enough knowledge to make informed decisions.
Oral contraceptive pills may be protective against anterior cruciate ligament tears in women, particularly in 15–19 year olds, a study has shown.
Researchers in Denmark found that newer combined hormonal contraceptives were still associated with a reduction in ovarian cancer risk in women of reproductive age.
The first combined oral contraceptive pill was licensed for ‘menstrual irregularities’ in 1957, and contraception three years later. Since then, millions of women have taken ‘the pill’.
Study explores the impact of both oral contraceptives and breastfeeding on womens’ risk of rheumatoid arthritis.
Barriers, such as a price premium, should be removed to allow easier access to emergency hormonal contraception.
An estimated 100 million women use the contraceptive pill, but surprisingly little is known about its effect on overall health.
Most women who take the contraceptive pill are not at increased risk of cancer overall and may actually gain some protection against certain cancers, researchers say.
Adding the CDK4/6 inhibitor palbociclib to hormone therapy can slow or stop tumour growth in women with early breast cancer, a study in the Journal of Clinical Oncology has shown.
By using Oncotype DX test technology, researchers behind the TAILORx trial have proven that invasive and often harmful chemotherapy needn’t be the only option for women with breast cancer.
ACE inhibitors and beta-blockers reduce risk of cardiotoxicity for some Herceptin patientsSubscription
Researchers conclude that prophylactic use of lisinopril or carvedilol should be considered in patients who could benefit from anthracycline treatment prior to trastuzumab (Herceptin).
Research has shown that testing for PIK3CA levels after taking palbociclib could help predict a progression-free survival, making it the first known biomarker for this therapy.
A previously reported association between analgesic use in pregnancy and childhood asthma is likely to result from confounding factors, researchers have concluded.
Neurotransmitter-affecting medicines used in pregnancy not linked to autism risk in offspringSubscription
Use of medicines targeting neurotransmitter systems during pregnancy is unlikely to influence estimates of autism spectrum disorder (ASD) in offspring, the authors of a study published in JAMA Psychiatry have concluded.
Pregnancy problems: a guide for pharmacySubscription
Pregnancy causes many changes to the body, some of which can result in troublesome symptoms. Here we explain what pharmacy teams can do to help women seeking advice.
In a study looking at placentas from caesarean deliveries, valproic acid had a significant impact on mRNA levels of major carriers for essential compounds such as folic acid, glucose, choline, thyroid hormones and serotonin.
Is hormone replacement therapy worth the risks?Subscription
The risks and benefits of hormone replacement therapy (HRT) have long been the source of confusion and controversy. Here we summarise the latest evidence to assist pharmacists in supporting patients thinking about HRT.
Hormone replacement therapy is associated with a small but significantly increased risk of Alzheimer’s disease, research published in The BMJ has found
Research has shown that neurokinin 3 receptor antagonism has a rapid effect on vasomotor symptoms of menopause